WebDisclosure WebDisclosure
Basculer en Français
8763 Companies
156834 Keywords
92417 Articles
84524 Press releases
Headlines Articles Press releases Athos Therapeutics Remove
  1. Home
  2. Companies
  3. Athos Therapeutics
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 10/16/2024 at 15:05, 8 months 24 days ago

    Athos Therapeutics Reports Promising Phase 1 Results for AI-Developed ATH-063

    Phase 1 Trial Autoimmune Diseases AI Drug Development ATH-063 Regulatory T Cells
  • BRIEF

    published on 10/16/2024 at 15:05, 8 months 24 days ago

    Athos Therapeutics annonce des résultats prometteurs de la phase 1 de son ATH-063 développé par IA

    Maladies Auto-immunes Essai De Phase 1 ATH-063 Cellules T Régulatrices Développement De Médicaments Par IA
  • PRESS RELEASE

    published on 10/16/2024 at 15:00, 8 months 24 days ago

    Athos Announces Positive Topline Phase 1 Data for its AI-Generated, Novel, Oral G9A Inhibitor ATH-063, Demonstrating Selective Expansion and Activation of Potent Anti-Inflammatory Regulatory T Cells

    Athos Therapeutics announces positive Phase 1 results for ATH-063, an oral small molecule G9A inhibitor for inflammatory bowel disease (IBD), confirming Treg activation and AI2 platform predictions
    Phase 1 Results ATH-063 Athos Therapeutics G9A Inhibitor Inflammatory Bowel Disease
    Logo of
Accesswire
  • Published on 07/09/2025 at 16:00, 4 hours 13 minutes ago

    Aeonian Receives Drill Permits for Koocanusa Project, Paving the Way for First Pass Testing of Sedimentary Copper Targets

  • Published on 07/09/2025 at 14:30, 5 hours 43 minutes ago

    Agassi Sports Entertainment Engages IBM to Help Elevate Racquet Sports Experience

  • Published on 07/09/2025 at 14:30, 5 hours 43 minutes ago

    Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement

  • Published on 07/09/2025 at 14:00, 6 hours 13 minutes ago

    Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Quebec and Two Federal Programs

  • Published on 07/09/2025 at 14:00, 6 hours 13 minutes ago

    Le traitement pour l’acné vulgaire de Bausch Health, Canada Inc., (Pr)CABTREO(MC) (gel de phosphate de clindamycine, d’adapalène et de peroxyde de benzoyle), est maintenant couvert par les régimes publics de l’Ontario, de la Nouvelle Écosse et p

View all ACCESSWIRE
EQS Group
  • Published on 07/09/2025 at 18:34, 1 hour 38 minutes ago

    2CRSi SA: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE

  • Published on 07/09/2025 at 18:33, 1 hour 40 minutes ago

    Funding Circle Holdings plc: POS-Transaction in Own Shares

  • Published on 07/09/2025 at 18:20, 1 hour 53 minutes ago

    Delticom AG: AGM approves dividend

  • Published on 07/09/2025 at 17:45, 2 hours 28 minutes ago

    Charwood Energy: Bilan semestriel du contrat de liquidité contracté avec Kepler Cheuvreux

  • Published on 07/09/2025 at 17:35, 2 hours 38 minutes ago

    EQS-Adhoc: Pyrum Innovations AG resolves cash capital increase from authorized capital with exclusion of subscription rights

View all EQS
Les Echos
  • Published on 07/09/2025 at 18:00, 2 hours 13 minutes ago

    COGELEC : Legrand and Cogelec Développement's shareholders sign an agreement for Legrand to acquire a majority stake in Cogelec, a French specialist in access control

  • Published on 07/09/2025 at 18:00, 2 hours 13 minutes ago

    COGELEC : Legrand et les actionnaires de Cogelec Développement concluent un accord en vue de l’acquisition par Legrand d’une participation majoritaire dans Cogelec, spécialiste français dans le contrôle d’accès

  • Published on 07/09/2025 at 18:00, 2 hours 13 minutes ago

    Bilan semestriel du contrat de liquidité au 30 juin 2025

  • Published on 07/09/2025 at 18:00, 2 hours 13 minutes ago

    Half-year liquidity contract statement June 30, 2025

  • Published on 07/09/2025 at 18:00, 2 hours 13 minutes ago

    AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/06/2025

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy